ImportRefusal LogoImportRefusal

Kinohimitsu Singapore

⚠️ Moderate Risk

FEI: 3012147042 • Singapore • SINGAPORE

FEI

FEI Number

3012147042

📍

Location

Singapore

🇸🇬

Country

SINGAPORE
🏢

Address

176 Paya Lebar Road, #04-02, Singapore, , Singapore

Moderate Risk

FDA Import Risk Assessment

43.2
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

13
Total Refusals
6
Unique Violations
3/31/2016
Latest Refusal
3/4/2016
Earliest Refusal

Score Breakdown

Violation Severity
51.1×40%
Refusal Volume
42.5×30%
Recency
0.0×20%
Frequency
100.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

4738×

LABELING

The article appears in violation of FPLA because of its placement, form and/or contents statement.

1185×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

2605×

FALSE

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(a)(1 ) of the FD&C Act in that the labeling is false or misleading in any particular.

32805×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

753×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

23001×

DIETARYLBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it is a dietary supplement that appears to be misbranded within the meaning of Section 403(s)(2)(B) of the FD&C Act in that the label or labeling fails to identify the product by using the term "dietary supplement", which term may be modified with the name of such an ingredient.

Refusal History

DateProductViolationsDivision
3/31/2016
41BGT99FOODS WITH SUPPLEMENTAL NUTRIENTS ADDED, WITH OR WITHOUT ARTIFICAL SWEETNERS
118NOT LISTED
3280FRNMFGREG
Los Angeles District Office (LOS-DO)
3/31/2016
54YYY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
118NOT LISTED
3280FRNMFGREG
Los Angeles District Office (LOS-DO)
3/31/2016
54YYY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
118NOT LISTED
3280FRNMFGREG
Los Angeles District Office (LOS-DO)
3/29/2016
54YCY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Los Angeles District Office (LOS-DO)
3/29/2016
54YCY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Los Angeles District Office (LOS-DO)
3/4/2016
54YYY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
2300DIETARYLBL
473LABELING
Los Angeles District Office (LOS-DO)
3/4/2016
54YYY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
473LABELING
75UNAPPROVED
Los Angeles District Office (LOS-DO)
3/4/2016
54YYY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
473LABELING
Los Angeles District Office (LOS-DO)
3/4/2016
31KYY99TEA, N.E.C.
260FALSE
473LABELING
Los Angeles District Office (LOS-DO)
3/4/2016
54YYY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
260FALSE
473LABELING
Los Angeles District Office (LOS-DO)
3/4/2016
54YYY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
260FALSE
473LABELING
Los Angeles District Office (LOS-DO)
3/4/2016
54YYY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
260FALSE
473LABELING
Los Angeles District Office (LOS-DO)
3/4/2016
54YYY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
260FALSE
473LABELING
Los Angeles District Office (LOS-DO)

Frequently Asked Questions

What is Kinohimitsu Singapore's FDA import refusal history?

Kinohimitsu Singapore (FEI: 3012147042) has 13 FDA import refusal record(s) in our database, spanning from 3/4/2016 to 3/31/2016.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Kinohimitsu Singapore's FEI number is 3012147042.

What types of violations has Kinohimitsu Singapore received?

Kinohimitsu Singapore has been cited for 6 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Kinohimitsu Singapore come from?

All FDA import refusal data for Kinohimitsu Singapore is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.